Fludarabine and Melphalan
Sponsors
Medical College of Wisconsin, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, First Affiliated Hospital of Zhejiang University
Conditions
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATIONAcute Myeloid LeucemiaAcute Myeloid Leukemia, AdultAllogeneic Hematopoietic Stem Cell TransplantationConditioningHIVLeukemiaLeukemia, Myelocytic, Acute
Phase 2
Phase 3
Reduced Intensity Regimen vs Myeloablative Regimen for Myeloid Leukemia or Myelodysplastic Syndrome (BMT CTN 0901)
TerminatedNCT01339910
Start: 2011-06-30End: 2017-10-16Updated: 2023-01-04
Reduced Intensity Conditioning Regimens for Acute Myeloid Leukemia and Myelodysplastic Syndrome
Enrolling by invitationNCT05674539
Start: 2023-02-15End: 2025-12-30Target: 200Updated: 2025-02-10
Fludarabine Plus Melphalan Versus Addition of Venetoclax to Fludarabine/Melphalan Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in AML/MDS Patients Aged > 50 Years: a Multicenter, Randomized, Phase 3 Trial
RecruitingNCT07396480
Start: 2026-03-01End: 2030-06-30Target: 186Updated: 2026-03-17